Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol - Donner, Thomas W.; Magder, Laurence S.; Zarbalian, Kiarash (Nutrition research (New York, N.Y.), 2010)
Keywords: Adult; Aged; Biological and medical sciences; blood glucose; blood lipids; Bulk sweeteners; Cholesterol, HDL - blood; D-tagatose; Diabetes control; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - physiopathology; Diabetes. Impaired glucose tolerance; Dietary Supplements; disease control; Drug Therapy, Combination; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Female; food intake; Gastroenterology and Hepatology; Gastrointestinal Diseases - etiology; Glycated Hemoglobin A - metabolism; glycemic control; glycemic effect; glycohemoglobin; HDL cholesterol; Hexoses - pharmacology; Hexoses - therapeutic use; high density lipoprotein; Humans; Hypoglycemic Agents - pharmacology; Hypoglycemic Agents - therapeutic use; Lipid modification; Male; Management. Various non-drug treatments. Langerhans islet grafts; Medical sciences; men; Middle Aged; noninsulin-dependent diabetes mellitus; nonnutritive sweeteners; nutritional intervention; Pilot Projects; Tagatose; weight loss; Weight Loss - drug effects; Weight loss agents; women; Weight loss agents; Bulk sweeteners; GlyHb; LDL; d-Tag; DM; Tagatose; Diabetes control; CHD; Lipid modification; HDL cholesterol; diabetes mellitus; low-density lipoprotein; d-tagatose; glycated hemoglobin; coronary heart disease; Endocrinopathy; Type 2 diabetes; Human; Weight loss; Metabolic diseases; Lipids; Diet therapy; Cholesterol HDL; Food intake; Sweetener; Supplementation; Lipoprotein HDL